Chang Zu

422 total citations
14 papers, 348 citations indexed

About

Chang Zu is a scholar working on Pharmaceutical Science, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Chang Zu has authored 14 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Chang Zu's work include Drug Solubulity and Delivery Systems (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Chang Zu is often cited by papers focused on Drug Solubulity and Delivery Systems (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Chang Zu collaborates with scholars based in China, Slovakia and United States. Chang Zu's co-authors include Xiuhua Zhao, Yiping Deng, Mingfang Wu, Weiwei Wu, Yuangang Zu, Ziqi Feng, Lingling Wang, Jiasheng Tu, Dongsheng He and Yan Shen and has published in prestigious journals such as Journal of Colloid and Interface Science, Nanoscale and International Journal of Pharmaceutics.

In The Last Decade

Chang Zu

14 papers receiving 346 citations

Peers

Chang Zu
Baishi Zu China
Chang Zu
Citations per year, relative to Chang Zu Chang Zu (= 1×) peers Baishi Zu

Countries citing papers authored by Chang Zu

Since Specialization
Citations

This map shows the geographic impact of Chang Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Zu more than expected).

Fields of papers citing papers by Chang Zu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Zu. The network helps show where Chang Zu may publish in the future.

Co-authorship network of co-authors of Chang Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Zu. A scholar is included among the top collaborators of Chang Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Zu. Chang Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chen, Qian, Yanan Li, Liping Huang, et al.. (2023). Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy. Nanomedicine Nanotechnology Biology and Medicine. 53. 102693–102693. 6 indexed citations
3.
Yu, Yinglan, Chang Zu, Dongsheng He, et al.. (2020). pH-dependent reversibly activatable cell-penetrating peptides improve the antitumor effect of artemisinin-loaded liposomes. Journal of Colloid and Interface Science. 586. 391–403. 38 indexed citations
5.
7.
Deng, Yiping, Fengjian Yang, Xiuhua Zhao, et al.. (2017). Improving the skin penetration and antifebrile activity of ibuprofen by preparing nanoparticles using emulsion solvent evaporation method. European Journal of Pharmaceutical Sciences. 114. 293–302. 17 indexed citations
8.
Wu, Mingfang, Bolin Lian, Yiping Deng, et al.. (2017). Resveratrol-loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles wrapping resveratrol nanoparticles: Preparation, characterization, and targeting effect on liver tumors. Journal of Biomaterials Applications. 32(2). 191–205. 27 indexed citations
9.
Zu, Yuangang, Xiuhua Zhao, Mingfang Wu, et al.. (2016). Preparation of inclusion complex of apigenin-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement. International Journal of Pharmaceutics. 511(2). 921–930. 76 indexed citations
10.
Li, Yuanyuan, Xiuhua Zhao, Yuangang Zu, et al.. (2016). Melatonin-loaded silica coated with hydroxypropyl methylcellulose phthalate for enhanced oral bioavailability: Preparation, and in vitro-in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics. 112. 58–66. 33 indexed citations
11.
Zu, Yuan Gang, Lingling Wang, Xiuhua Zhao, et al.. (2016). Purification of Ginkgo biloba Extract by Antisolvent Recrystallization. Chemical Engineering & Technology. 39(7). 1301–1308. 17 indexed citations
12.
Wang, Lingling, Xiuhua Zhao, Yuangang Zu, et al.. (2016). Enhanced dissolution rate and oral bioavailability of ginkgo biloba extract by preparing nanoparticles via emulsion solvent evaporation combined with freeze drying (ESE-FR). RSC Advances. 6(81). 77346–77357. 11 indexed citations
13.
Zhao, Xiuhua, Yiping Deng, Ying Zhang, et al.. (2016). Silymarin nanoparticles through emulsion solvent evaporation method for oral delivery with high antioxidant activities, bioavailability, and absorption in the liver. RSC Advances. 6(95). 93137–93146. 24 indexed citations
14.
Zu, Chang, et al.. (2013). Enhanced water-solubility of Licorice extract microparticle prepared by antisolvent precipitation process. Advanced Powder Technology. 25(2). 787–794. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026